The groundbreaking therapy of the medication represents a major development in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide974112.idblogz.com/42360182/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment